Honeysuckle Oil Benefits: What the Research Covers and Misses
Search "honeysuckle oil benefits" and you get claims that sound like they rest on research. The research exists, but it is almost all on dried flower bud (Jin Yin Hua) preparations, tested in cell dishes, animals and a few small clinical series. We found no study of a solvent-extracted honeysuckle absolute applied to skin or inhaled by people. We sell the absolute for scent and craft, we make no medical claim for it, and nothing below should be read as one.
Honeysuckle Absolute
Our own Honeysuckle Absolute, in sizes from 0.5 oz to bulk.
From $13.99
Shop Now →Three materials share one name
The word "honeysuckle" in a paper title can mean a water decoction of dried flower buds, a distilled or CO2-extracted volatile oil of dried flowers, or (in perfumery) an absolute from fresh flowers made with hexane and then ethanol. They are not interchangeable. The 2011 review by Shang and colleagues notes that composition varies with habitat, harvest time, plant part, extraction method and drying, and cites one study that found linalool above 14% in fresh flowers but below 0.4% in dried flowers (Shang et al., 2011). If drying alone moves one major aroma compound by a factor of more than 35, a result from dried material cannot be carried over to a different material made from fresh flowers.
What the studies actually did
| Source | Material and model | What was reported | Limit |
|---|---|---|---|
| Shang et al., 2011, J Ethnopharmacol (review) | Flos Lonicerae and other plant parts; cell, animal and traditional-use literature | A supercritical CO2 extract gave 1.08% volatile oil from Flos Lonicerae, and that oil was tested in a mouse ear-swelling model and the authors report an anti-inflammatory result | Dried flower, mouse, not a fragrance material |
| Same review, toxicology section | Oral doses: leaf ethanol extract in rats; flower buds in mice | 5,000 mg/kg single oral dose in rats with no mortality; mouse acute oral LD50 above 15 g/kg for flower buds. The authors still write that a chronic toxicity study is needed | Oral animal data on other preparations; says nothing about skin or inhalation of an absolute |
| Yeh et al., 2022, Front Pharmacol | Honeysuckle ethanol extract on human cell lines and in cell-free assays | Spike-ACE2 binding fell to about 30% of control and IL-6 release from stimulated THP-1 cells was lower; extract concentrations tested ran from 50 to 1,000 µg/ml | In vitro only; no participants; authors call for in vivo work |
| Systematic review of Lonicerae japonicae flos and Lonicerae flos (PMC7088551) | Small clinical series, mostly of Shuanghuanglian preparations or added JYH decoction | For example 120 cases (oral ulcer), 92 patients (syphilis), 55 children (viral pneumonia), 80 cases (rash) | Most lacked a placebo group; safety data in children, pregnant women and the elderly lacking |
| Zheng et al., 2022, Front Pharmacol (review) | Lonicerae Japonicae Flos, 1986 to 2022 literature | Studies of activity against bacteria mostly lacked positive controls; no unified quality standard exists | The reviewers' own caveats |
| Gao et al., 2026, Molecules (review) | Honeysuckle as a food-medicine resource: 161 original articles and 7 clinical or translational reports | Mostly preclinical; none of the listed functional-food products evaluated in published randomized controlled trials; safety data described as "surprisingly limited" | Mentions volatile oils in passing and does not examine aroma or aromatherapy |
Links to each are in the source list at the end. The last row matters most for this page: the 2026 review that sweeps up the whole honeysuckle literature does not address aroma use, so there is no body of aroma evidence to summarize.
Three leaps every "benefit" claim has to make
Leap one: material. From a dried-bud extract to an absolute. The extraction solvents differ, the plant stage differs, and our published COA gives no constituent table, only a relative density of 0.989, a refractive index of 1.509, an optical rotation of +1.88 degrees, appearance and smell. We cannot say what is in the batch beyond that, so even a linalool-based argument would be guesswork. The review by Gao and colleagues lists linalool among honeysuckle volatile constituents and mentions sedative effects in passing; that is a statement about a compound, not about our oil.
Leap two: dose and route. The cell work above included extract at 500 µg/ml, which is 0.05% weight per volume (arithmetic: 500 µg is 0.5 mg, and 0.5 mg per ml is 0.05 g per 100 ml). Our skin guidance is 0.5% to 2% of the absolute in a carrier. Those two numbers cannot be compared, because one is a water or ethanol extract in culture medium and the other is an undiluted absolute in oil on skin. We mention it only to show that "it worked in a dish" gives no usable dose for anything.
Leap three: cells and animals to people. The clinical items in the table were small, mostly uncontrolled by placebo, and tested oral preparations. None used a fragrance absolute.
How to read the next headline
When a page cites a honeysuckle study, ask four things in order. What was the material: dried bud, hydrodistilled or CO2 volatile oil, water or ethanol extract, or an absolute? What was the model: a cell line, a mouse, or people, and how many? What was the dose, in what vehicle, by what route? What did the authors themselves list as limits? In the table above, the answer to the first question is never "a solvent-extracted absolute from fresh flowers", and the answer to the third is never "diluted in a carrier and put on skin". A page that skips those four questions is selling a conclusion the source never reached.
It also helps to know that the flower is a traditional Chinese medicine crop. Our how-its-made page says the blossom is grown in China as a medicinal crop there. That tells you where the plant material comes from. It does not tell you the batch was harvested at the stage a pharmacopoeia describes, or that medicinal research on the herb applies to a fragrance extract made from it.
What we say instead
For skin use the baseline is our own safety copy: dilute to 0.5% to 2% in a carrier such as jojoba, patch test first, keep away from eyes, children and pets, not for internal use, and stop if irritation occurs. Under US law the label and marketing claims decide how a product is classed. FDA states that intended use decides whether a product is a cosmetic or a drug, and that disease, pain or sleep claims on aromatherapy products put them on the drug side of the line (FDA, Aromatherapy, page dated 2023). That is why this shop describes scent and use, not outcomes.
If your question is about a health condition, it belongs with a physician or, for herbal medicine, a licensed practitioner of traditional Chinese medicine, not with a fragrance supplier. The dried herb and the absolute are sorted out in our comparison of Jin Yin Hua and aromatherapy. For what each study found in the scent chemistry, see the composition review. For the skin questions people ask next, read dilution and patch tests and the sensitization article, and for the other claims in circulation, the myths and facts check.
In short, honeysuckle has a real research literature, and none of it describes the absolute we sell. Buy it for how it smells, and ask a clinician about anything medical.
Honeysuckle Absolute
Honeysuckle Absolute from our own shop, in sizes from 0.5 oz to bulk.
From $13.99
Shop Now →Sources & Further Reading
- Shang X, Pan H, Li M, Miao X, Ding H, 2011. Lonicera japonica Thunb.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol 138(1):1-21. pmc.ncbi.nlm.nih.gov/PMC7127058
- Yeh Y-C et al., 2022. Honeysuckle and Huangqi suppress SARS-CoV-2 entry and COVID-19 related cytokine storm in vitro. Front Pharmacol 12:765553. pmc.ncbi.nlm.nih.gov/PMC8990830
- Lonicerae japonicae flos and Lonicerae flos: a systematic review of ethnopharmacology, phytochemistry and pharmacology (PMC copy). pmc.ncbi.nlm.nih.gov/PMC7088551
- Zheng S et al., 2022. Systematic review of Lonicerae Japonicae Flos: a significant food and traditional Chinese medicine. Front Pharmacol 13:1013992. frontiersin.org/10.3389/fphar.2022.1013992
- Gao J, Li L, Li Y, 2026. Honeysuckle as a food-medicine resource: a review of its multi-target pharmacological effects and emerging applications. Molecules 31(16):2792. pmc.ncbi.nlm.nih.gov/PMC13515960
- US FDA, 2023. Aromatherapy. fda.gov/cosmetics/cosmetic-products/aromatherapy